Eric A. Shuey has more than twenty years of corporate finance and private equity investing experience. His previous experience includes serving as the Chief Financial Officer of Liberty Dialysis Holdings, Inc. He was also part of the management team that grew Liberty into the 3rd largest chain of dialysis centers in the US operating under the Liberty Dialysis and Renal Advantage brands. Prior to joining Liberty Dialysis, he served as a Director at DB Capital Partners, the private equity arm of Deutsche Bank responsible for over $10 billion in assets, and a Principal at Aurora Capital Group, a $1 billion private equity firm.
Eric has an MBA from the Wharton School of Business and has completed the coursework for a Ph.D. in Management at the Wharton School. He holds a BA from California State University, Fullerton with highest honors.
He is a board member of the following companies:
- Apixio Inc.
- National Cardiovascular Partners
- Remedy Partners
- Sound Physicians, Inc.